What is the CD4 count threshold below which treatment for asymptomatic HIV is indicated?
Which of the following is seen in antiphospholipid antibody syndrome?
Pressure sores usually occur when external pressure exceeds capillary occlusive pressure over which value?
In burns, which of the following is decreased, except?
Phlycten is due to which of the following?
Which of the following is true regarding the autonomic nervous system?
Which thalamic nucleus controls the basal ganglia function?
Preformed antibodies cause which type of transplant rejection?
Which of the following is true about proto-oncogenes?
Phagocytosis in nervous tissue is primarily performed by which type of cell?
Explanation: **Explanation:** The initiation of Antiretroviral Therapy (ART) in asymptomatic HIV patients is primarily guided by the **CD4 T-lymphocyte count**, which serves as a surrogate marker for immune competence [1]. According to the classic WHO and NACO guidelines (frequently tested in NEET-PG), a CD4 count of **350 cells/mm³** is the critical threshold where the risk of opportunistic infections increases significantly, necessitating the start of treatment even in the absence of symptoms [1]. * **Option B (Correct):** 350 cells/mm³ was established as the standard threshold for asymptomatic patients to prevent clinical progression and reduce the community viral load [1]. (Note: Modern "Test and Treat" strategies recommend ART regardless of CD4 count, but for exam purposes, 350 remains the classic benchmark for asymptomatic initiation). * **Option A:** 200 cells/mm³ is the threshold for defining **AIDS** and the point at which prophylaxis for *Pneumocystis jirovecii* pneumonia (PCP) must begin [2]. * **Options C & D:** While counts of 400 or 500 cells/mm³ indicate better immune status, they were historically considered "monitoring phases" rather than mandatory initiation points for asymptomatic individuals in resource-limited settings. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Clinical Staging:** ART is indicated for all patients in **Stage III and IV**, regardless of CD4 count. * **Pregnancy/HBV Co-infection:** ART is started immediately regardless of CD4 count [1]. * **Most Common Opportunistic Infection (India):** Tuberculosis. * **Prophylaxis:** Start Cotrimoxazole (CPT) if CD4 <200 cells/mm³ [2].
Explanation: **Explanation:** **Antiphospholipid Antibody Syndrome (APS)** is an autoimmune prothrombotic state characterized by recurrent arterial or venous thrombosis and pregnancy complications [1]. **Why Option D is correct:** The term "antiphospholipid" is slightly misleading because the antibodies do not bind directly to phospholipids. Instead, they target **plasma proteins (glycoproteins)** that are bound to anionic phospholipids. The most clinically significant target is **Apolipoprotein H**, commonly known as **Beta-2 Glycoprotein I (β2-GPI)** [1]. Other targets include prothrombin. Therefore, APS is fundamentally characterized by the presence of **anti-glycoprotein antibodies** [1]. **Analysis of Incorrect Options:** * **Option A (Beta 2 microglobulin):** This is a component of MHC Class I molecules and a marker for cell turnover (often elevated in multiple myeloma or lymphoma). It is frequently confused with *Beta-2 Glycoprotein I*, which is the actual target in APS. * **Option B (Anti-nuclear antibody - ANA):** While ANA is the screening test for Systemic Lupus Erythematosus (SLE), and APS can occur secondary to SLE, ANA itself is not diagnostic or specific for APS. * **Option C (Anti-centromere antibody):** This is a specific marker for **Limited Cutaneous Systemic Sclerosis (CREST syndrome)**, not APS. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Triad (Laboratory):** Lupus anticoagulant (LA), Anti-cardiolipin antibodies (aCL), and Anti-β2-glycoprotein I antibodies [1]. * **False Positive VDRL:** Patients with APS often show a false positive syphilis test (VDRL/RPR) because the reagent contains cardiolipin. * **Coagulation Paradox:** In vitro, Lupus Anticoagulant **prolongs aPTT** (acting as an anticoagulant), but in vivo, it is highly **prothrombotic** [1]. * **Clinical Hallmark:** Recurrent miscarriages and "white clots" (arterial thrombosis) [1].
Explanation: Explanation: The development of pressure sores (decubitus ulcers) is primarily driven by ischemia resulting from external pressure [1]. The critical threshold for this process is the **Capillary Filling Pressure (or Capillary Occlusive Pressure)**. **1. Why 30 mmHg is Correct:** In healthy individuals, the average arteriolar capillary pressure ranges between **25 to 32 mmHg**. When external pressure exceeds this range—specifically the threshold of **30 mmHg**—it overcomes the internal hydrostatic pressure of the capillaries. This leads to vessel collapse, occlusion of blood flow, and subsequent tissue hypoxia. If this pressure is maintained for more than 2 hours, irreversible cell death and tissue necrosis occur, forming a pressure sore. **2. Analysis of Incorrect Options:** * **20 mmHg & 25 mmHg:** While these values represent lower-end venous or mid-capillary pressures, they are generally insufficient to cause total arteriolar occlusion in a patient with normal systemic blood pressure. * **35 mmHg:** This value is well above the occlusive threshold. While it certainly causes ischemia, the *minimal* pressure required to initiate the pathological process (the standard definition of capillary occlusive pressure) is clinically accepted as 30 mmHg. **3. Clinical Pearls for NEET-PG:** * **Common Sites:** The **sacrum** is the most common site (30-40%), followed by the **ischial tuberosity** and **greater trochanter** [1]. * **The "Tip of the Iceberg" Phenomenon:** Extensive deep tissue damage often exists under seemingly small superficial skin breaks. * **Prevention:** The "2-hour rule" for repositioning patients is based on the time it takes for ischemia to transition into necrosis. * **Grading:** Stage I involves non-blanchable erythema; Stage IV involves full-thickness loss with exposed bone, tendon, or muscle [1].
Explanation: The pathophysiology of burns involves a massive systemic inflammatory response. The question asks which parameter is **decreased, except** (meaning, which of the following is actually **increased**). **1. Why "Capillary Permeability" is the correct answer:** In burn injuries, there is an immediate and massive release of inflammatory mediators (such as histamine, kinins, and prostaglandins). These mediators cause a significant **increase in capillary permeability** [1]. This leads to the leakage of plasma proteins and fluids from the intravascular space into the interstitial space (forming edema), which is the hallmark of burn shock. Since it increases rather than decreases, it is the correct "except" choice. **2. Why the other options are incorrect:** * **Immunity (Decreased):** Burns lead to profound immunosuppression [1]. There is a loss of the skin barrier, impaired T-cell function, and decreased neutrophil activity, making the patient highly susceptible to sepsis. * **Intravascular Volume (Decreased):** Due to the increased capillary permeability mentioned above, fluid shifts out of the vessels (third-spacing). This results in **hypovolemia** and hemoconcentration, necessitating aggressive fluid resuscitation [1]. **Clinical Pearls for NEET-PG:** * **Parkland Formula:** Used for fluid resuscitation in the first 24 hours: $4 \text{ ml} \times \text{Body Weight (kg)} \times \text{Total Burn Surface Area (\% TBSA)}$. * **Rule of Nines:** The most common method to estimate TBSA in adults. * **Curling’s Ulcer:** An acute gastric erosion/ulcer occurring as a complication of severe burns due to reduced mucosal blood flow. * **Zone of Coagulation:** The central, most severely damaged area of a burn where tissue necrosis is irreversible.
Explanation: **Explanation:** **Phlyctenular Keratoconjunctivitis (Phlycten)** is a localized, nodular inflammatory response of the conjunctiva or cornea. It is characterized as a **Type IV (delayed-type) hypersensitivity reaction** to a foreign protein or antigen to which the patient has been previously sensitized. **1. Why Endogenous Allergy is Correct:** The term "endogenous allergy" refers to a hypersensitivity reaction triggered by an internal antigen (bacterial protein) already present in the body. The most common causative agent is **Mycobacterium tuberculosis** (tubercular protein), followed by **Staphylococcus aureus** (cell wall proteins from chronic blepharitis). Since the reaction is against an internal microbial protein rather than an external allergen, it is classified as an endogenous allergy. **2. Why Other Options are Incorrect:** * **Exogenous Allergy:** This refers to reactions caused by external allergens like pollen, dust, or animal dander (e.g., Vernal Keratoconjunctivitis). Phlycten is not triggered by these environmental factors. * **Viral/Fungal Keratitis:** These are direct infectious processes where the pathogen actively invades and destroys corneal tissue. Phlycten is an **immunological** (allergic) reaction, not a direct infection, although it is triggered by the presence of microbial proteins. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Presentation:** A small, pinkish-white nodule (phlycten) surrounded by a zone of hyperemia, usually near the limbus. * **Symptoms:** Intense photophobia, lacrimation, and blepasprospasm (especially when the cornea is involved). * **Key Association:** In the Indian subcontinent, always rule out **Tuberculosis** in a child presenting with phlycten. * **Treatment:** Topical steroids (to control the allergy) and treatment of the underlying cause (e.g., ATT for TB or lid hygiene for Staphylococcal blepharitis).
Explanation: ### Explanation **Correct Option: C** The **superior hypogastric plexus (SHP)** is a retroperitoneal structure located in the pre-aortic space [1]. It is situated specifically at the level of the **aortic bifurcation** (L4 level) and the **promontory of the sacrum/L5 vertebra**. It is the continuation of the intermesenteric plexus and serves as the primary gateway for sympathetic fibers entering the pelvis. **Analysis of Incorrect Options:** * **Option A:** The sympathetic outflow is strictly **Thoracolumbar (T1–L2)** [1]. It exits the CNS via the ventral roots of spinal nerves along with axons of alpha and gamma-motor neurons, not cranial nerves [1]. * **Option B:** The parasympathetic outflow is **Craniosacral**. It involves cranial nerves **III, VII, IX, and X**, as well as the **S2–S4** spinal segments (pelvic splanchnic nerves). * **Option D:** The SHP contains postganglionic sympathetic fibers, visceral afferents, and parasympathetic fibers (from the inferior hypogastric plexus), but it does **not** contain the sympathetic chain. The sympathetic chains (trunks) lie paravertebrally, lateral to the plexus [1]. **Clinical Pearls for NEET-PG:** * **Presacral Neurectomy:** Surgical excision of the SHP is sometimes performed to treat chronic pelvic pain or severe dysmenorrhea. * **Iatrogenic Injury:** Damage to the SHP during rectal or aortic surgery can lead to **retrograde ejaculation** in males because the sympathetic system controls the closure of the internal urethral sphincter during emission. * **Nerve Types:** Remember: **Sympathetic** = Thoracolumbar [1]; **Parasympathetic** = Craniosacral [2].
Explanation: **Explanation:** The **Anterior Nucleus** of the thalamus is the correct answer because it serves as a critical relay station in the **Papez circuit**, which connects the mammillary bodies to the cingulate gyrus [1]. While traditionally associated with the limbic system and memory, it plays a vital role in the functional circuitry of the **basal ganglia**, specifically receiving inputs from the globus pallidus and substantia nigra via the ventral anterior (VA) complex to modulate motor planning and executive function [2]. **Analysis of Incorrect Options:** * **B. Intralaminar Nucleus:** These nuclei (e.g., centromedian) primarily handle arousal and consciousness via the Reticular Activating System (RAS) [1]. While they have connections to the striatum, they are not the primary controllers of basal ganglia output in this context. * **C. Dorsal Nucleus:** The lateral dorsal (LD) and lateral posterior (LP) nuclei are mainly involved in sensory integration and have stronger links to the parietal cortex rather than the motor-heavy basal ganglia loops. * **D. Pulvinar Nucleus:** This is the largest nucleus of the thalamus. Its primary function is visual processing and integration (connecting the superior colliculus to the visual association cortex), not motor control. **High-Yield Facts for NEET-PG:** * **Ventral Anterior (VA) & Ventral Lateral (VL):** These are the primary "motor nuclei" of the thalamus. VL receives input from the **Cerebellum**, while VA receives input from the **Basal Ganglia** [2]. * **Papez Circuit Path:** Hippocampus → Fornix → Mammillary bodies → **Anterior Thalamic Nucleus** → Cingulate Gyrus → Entorhinal Cortex. * **Clinical Pearl:** Lesions in the anterior nucleus can lead to **Korsakoff syndrome** (anterograde amnesia) due to its role in the limbic circuit.
Explanation: ### Explanation **Correct Option: A. Hyperacute rejection** Hyperacute rejection occurs within minutes to hours after transplantation [1]. It is mediated by **preformed antibodies** (Type II hypersensitivity) present in the recipient's serum that react against the donor's antigens (usually ABO blood group or HLA antigens) [1]. These antibodies bind to the vascular endothelium of the graft, activating the complement system and the coagulation cascade [1]. This leads to rapid thrombosis, ischemia, and irreversible necrosis of the transplanted organ. **Incorrect Options:** * **B. Acute rejection:** Occurs within days to weeks. It is primarily **T-cell mediated** (Type IV hypersensitivity) involving CD8+ cytotoxic T cells and CD4+ helper T cells reacting against donor HLA [1]. * **C. Chronic rejection:** Occurs months to years post-transplant. It involves both humoral and cellular immunity, leading to **intimal thickening** and fibrosis (e.g., bronchiolitis obliterans in lungs or accelerated atherosclerosis in heart grafts) [1]. * **D. Acute humoral rejection:** Also known as Antibody-Mediated Rejection (AMR), it occurs over days. Unlike hyperacute rejection, the antibodies are often developed *de novo* after the transplant rather than being preformed [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Prevention:** Hyperacute rejection is prevented by **cross-matching** (testing recipient serum against donor lymphocytes) and ABO blood typing [1]. * **Morphology:** The hallmark of hyperacute rejection is **fibrinoid necrosis** of graft vessels and widespread thrombosis [1]. * **Treatment:** There is no effective treatment for hyperacute rejection; the graft must be surgically removed immediately [1]. * **Graft-versus-Host Disease (GVHD):** Contrast this with rejection; in GVHD, the *grafted* T cells attack the *host* tissues (common in bone marrow transplants).
Explanation: **Explanation:** **Proto-oncogenes** are normal cellular genes that encode proteins responsible for regulating cell growth, division, and differentiation [1]. They act as the "accelerators" of the cell cycle. 1. **Why Option A is Correct:** In their normal state, proto-oncogenes are essential for physiological processes. They produce proteins like growth factors (e.g., PDGF), growth factor receptors (e.g., ERBB1), signal transducers (e.g., RAS), and nuclear transcription factors (e.g., MYC) that ensure healthy cell proliferation. 2. **Analysis of Incorrect Options:** * **Option B:** While proto-oncogenes *can* be converted into oncogenes via mutation, amplification, or translocation, this is a pathological event [2]. The question asks for a fundamental truth about the genes themselves; their primary biological role is normal growth [1]. * **Option C:** Overexpression of specific proto-oncogenes (like *c-MYC* in Burkitt Lymphoma) is associated with lymphomas, but "much over expression" is a vague clinical consequence rather than a defining characteristic of the gene class. * **Option D:** Retinoblastoma is caused by the mutation/inactivation of the **RB gene**, which is a **Tumor Suppressor Gene** (the "brakes"), not a proto-oncogene [1]. **High-Yield Clinical Pearls for NEET-PG:** * **RAS:** The most common proto-oncogene mutated in human cancers (Point mutation) [2]. * **c-MYC:** Translocation t(8;14) is characteristic of Burkitt Lymphoma. * **ERBB2 (HER2/neu):** Amplified in breast cancer; targeted by Trastuzumab. * **Knudson’s Two-Hit Hypothesis:** Applies to Tumor Suppressor Genes (like RB), where both alleles must be inactivated for cancer to develop. In contrast, a mutation in just one allele of a proto-oncogene is sufficient to promote oncogenesis (Gain-of-function).
Explanation: **Explanation:** **Microglia** are the specialized resident macrophages of the Central Nervous System (CNS) [1]. They are derived from **mesodermal yolk sac progenitors** (unlike other glial cells which are ectodermal) [1]. In their "activated" state, microglia undergo morphological changes to become mobile, amoeboid cells that perform **phagocytosis**, clearing cellular debris, damaged neurons, and infectious agents [1][2]. They act as the primary immune defense in the brain and spinal cord. **Analysis of Incorrect Options:** * **Neuroglia (Option A):** This is a broad category that includes astrocytes, oligodendrocytes, and microglia [1]. While microglia are a subtype of neuroglia, "Microglia" is the most specific and accurate answer. Other neuroglia like astrocytes provide structural and metabolic support but are not primarily phagocytic. * **Fibroblasts (Option B):** These are connective tissue cells found in the PNS (endoneurium/perineurium) and the meninges, but they are not present within the actual parenchyma of the CNS. Their primary role is collagen synthesis, not phagocytosis. * **Axons (Option C):** These are the long, slender projections of neurons that conduct electrical impulses away from the cell body. They are structural components of nerve cells and have no phagocytic capability. **High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Microglia are the only CNS cells of **mesodermal** origin (High-yield MCQ) [1]. * **Gitter Cells:** When microglia ingest large amounts of lipids (e.g., in areas of cerebral infarction/necrosis), they are referred to as **Gitter cells** or "glitter cells." * **HIV Pathology:** Microglia are the primary targets of HIV in the brain; they fuse to form **multinucleated giant cells**, a hallmark of HIV-associated dementia [1]. * **PNS Equivalent:** In the Peripheral Nervous System, phagocytosis is primarily performed by **macrophages** and **Schwann cells** (during Wallerian degeneration) [3].
Organization of the Nervous System
Practice Questions
Spinal Cord Anatomy
Practice Questions
Brainstem Anatomy
Practice Questions
Cerebellum
Practice Questions
Diencephalon
Practice Questions
Cerebral Cortex
Practice Questions
Basal Ganglia
Practice Questions
Limbic System
Practice Questions
Cranial Nerves
Practice Questions
Autonomic Nervous System
Practice Questions
Neural Pathways and Tracts
Practice Questions
Neurovascular Anatomy
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free